Status: current, Defined. Date: 31-Oct 2021. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4651602015 | Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
4651603013 | Product containing lidocaine and metronidazole and sucralfate in cutaneous dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form | Is a | Lidocaine- and metronidazole- and sucralfate-containing product | true | Inferred relationship | Some | ||
Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form | Is a | Metronidazole-containing product in cutaneous dose form | true | Inferred relationship | Some | ||
Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form | Is a | Lidocaine-containing product in cutaneous dose form | true | Inferred relationship | Some | ||
Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form | Has manufactured dose form | Cutaneous dose form | true | Inferred relationship | Some | ||
Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form | Plays role | Antibacterial therapeutic role | true | Inferred relationship | Some | ||
Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form | Has active ingredient | Metronidazole | true | Inferred relationship | Some | 1 | |
Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form | Has active ingredient | Sucralfate | true | Inferred relationship | Some | 2 | |
Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form | Has active ingredient | Lidocaine | true | Inferred relationship | Some | 3 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Lidocaine and metronidazole and sucralfate only product in cutaneous dose form | Is a | True | Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form | Inferred relationship | Some | |
Lidocaine hydrochloride 40 mg/g and metronidazole 10 mg/g and sucralfate 70 mg/g cutaneous cream | Is a | True | Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form | Inferred relationship | Some |
This concept is not in any reference sets